Rapid Deployment of Prior Authorization Policies
In an effort to minimize the cost curve, payers have been adjusting their utilization management policies, spurred by the approval of several costly new hepatitis C medications.
Keeping an Eye on Hepatitis C Virus Drug Approvals
With the recent approval of new hepatitis C treatments, payers are increasingly concerned with controlling costs in this category through policies that may affect treatment decisions.
2 Clarke Drive Cranbury, NJ 08512